finerenone
bayer
['finerenone']
#esccongress | fidelity: finerenone demonstrated significant on-treatment reduction in the incidence of all-cause and cv mortality vs placebo, and lowered the risk of sudden cardiac death. the effect on mortality was consistent in patients across baseline egfr and uacr values. 
Latest research in cardiology | Breaking news, insights, interviews, live tweeting and updates from major conferences. Co-published by @ilpensiero | @think2it